OOIR: Observatory of International Research

Papers

(The TQCC of Circulation-Cardiovascular Quality and Outcomes is 10. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-08-01 to 2026-08-01.)

Article	Citations
Redefining the Rules of Revascularization: Lessons From ISCHEMIA for the Future of Appropriate Use Criteria	147
Seeing Beyond the Surface: Is Intravascular Imaging Cost-Effective?	131
Drones for Saving Life: Reimagining War Technology	99
From Manual to Modern: Accelerating Health Care Transformation With Automatized Electronic Medical Record Registries	86
Implementation of an Atrial Fibrillation Decision Aid Care Pathway in the Emergency Department Reduces Atrial Fibrillation Hospitalizations	71
Utilizing Quality of Life Adjusted Days Alive and Out of Hospital in Heart Failure Clinical Trials	64
Disability-Adjusted Life Years Due to Pediatric Out-of-Hospital Cardiac Arrest in the United States: A CARES Surveillance Group Study	61
Sedentary Behavior and Cardiac Events and Mortality After Hospitalization for Acute Coronary Syndrome Symptoms: A Prospective Study	53
2024 ACC/AHA Clinical Performance and Quality Measures for Adults With Valvular and Structural Heart Disease: A Report of the American Heart Association/American College of Cardiology Joint Committee	53
Developing an Individualized Patient Decision Aid for Chronic Coronary Disease Based on the ISCHEMIA Trial: A Mixed-Methods Study	46
Better: Reflections on Retraction and Republication in Science	45
Association of Neighborhood Violent Crime With Hypertension-Related Emergency Department Visits in Chicago	44
Letter by Rich-Edwards et al Regarding Article, “Assessing the Accuracy of Cardiovascular Disease Prediction Using Female-Specific Risk Factors in Women Aged 45 to 69 Years in the UK Biobank Study”	41
Evaluation of Peer Review of Percutaneous Coronary Intervention Operator Performance	41
Can Observational Data and Target Trial Emulation Inform Cardiovascular Disease Prevention and Management Guidelines?	41
Estimating Vitamin K Antagonist Anticoagulation Benefit in People With Atrial Fibrillation Accounting for Competing Risks: Evidence From 12 Randomized Trials	40
Increasing Uptake of Depression Screening and Treatment Guidelines in Cardiac Patients: A Behavioral and Implementation Science Approach to Developing a Theory-Informed, Multilevel Implementation Stra	39
Long-Term Outcomes for Out-of-Hospital Cardiac Arrest in Elderly Patients: An Analysis of Cardiac Arrest Registry to Enhance Survival Data Linked to Medicare Files	38
Predicting Mortality in Patients Hospitalized With Acute Myocardial Infarction: From the National Cardiovascular Data Registry	38
Assessing the Relevance of the Kansas City Cardiomyopathy Questionnaire in Patients With Tricuspid Regurgitation: The Tri-QOL Qualitative Study	35
Community Socioeconomic Status, Acute Cardiovascular Hospitalizations, and Mortality in Medicare, 2003 to 2019	34
Association of Use and Dose of Lipid-Lowering Therapy Post Acute Myocardial Infarction With 5-Year Survival in Older Adults	34
PREVENT Equations: A New Era in Cardiovascular Disease Risk Assessment	34
Patients’ Perspectives Regarding Generator Exchanges of Implantable Cardioverter Defibrillators	32
Introducing the OUTPACE Framework for Health Care Quality Improvement	31

Examining Healthy Lifestyles as a Mediator of the Association Between Socially Determined Vulnerabilities and Incident Heart Failure	31
Comparison of Atherosclerotic Cardiovascular Risk Factors and Cardiometabolic Profiles Between Current and Never Users of Marijuana	29
Validity of Patient-Reported Outcomes Measurement Information System Physical, Mental, and Social Health Measures After Left Ventricular Assist Device Implantation and Implications for Patient Care	29
Patient and Physician Perspectives on Cardiovascular Risk: A Multicenter Survey of Communication Gaps Among Hospitalized Patients in Spain	29
Centering Medical Ethics Into Cardiovascular Medicine	29
Development of an Innovative Decision-Aid to Better Align Patients’ Implantable Cardioverter Defibrillator Shock Status With Goals of Care	28
Evidence for the Association Between Adverse Childhood Family Environment, Child Abuse, and Caregiver Warmth and Cardiovascular Health Across the Lifespan: The Coronary Artery Risk Development in Youn	28
Artificial Intelligence Applications for Electrocardiography to Define New Digital Biomarkers of Cardiovascular Risk	28
Characterizing the Accuracy of International Classification of Diseases, Tenth Revision Administrative Claims for Aortic Valve Disease	28
Advance Care Planning and End-of-Life Education in Heart Failure: Insights From the NCDR PINNACLE Registry	28
Guideline-Directed Medical Therapy Attainment and Outcomes in Dialysis-Requiring Versus Nondialysis Chronic Kidney Disease in the ISCHEMIA-CKD Trial	27
Referral Networks, Racial Inequity, and Hospital Quality for Open Heart Surgery	26
Examining the Linear Association Between Blood Pressure Levels and Cardiovascular Diseases in the Absence of Major Risk Factors in China	26
Long-Term Clinical Outcomes Following the WATCHMAN Device Use in Medicare Beneficiaries	24
Insurance-Based Disparities in Stroke Center Access in California: A Network Science Approach	24
Target Aortic Stenosis: A National Initiative to Improve Quality of Care and Outcomes for Patients With Aortic Stenosis	24
Medicaid Expansion Under the Affordable Care Act and Association With Cardiac Care: A Systematic Review	24
2024 ACC/AHA Key Data Elements and Definitions for Social Determinants of Health in Cardiology: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Da	24
Reach Out Emergency Department: A Randomized Factorial Trial to Determine the Optimal Mobile Health Components to Reduce Blood Pressure	23
Correction to: Eligibility for Cardiovascular Risk Reduction Therapy in the U.S. Based on SELECT Trial Criteria: Insights from the National Health and Nutrition Examination Survey	22
Quality of Life in Subcutaneous or Transvenous Implantable Cardioverter-Defibrillator Patients: A Secondary Analysis of the PRAETORIAN Trial	21
Cardiovascular Disease Prevention With mHealth Innovations: Transforming Wellness Through Wireless	20
Correction to: 2025 AHA/ACC Clinical Performance and Quality Measures for Patients With Chronic Coronary Disease: A Report of the American College of Cardiology/American Heart Association Joint Commit	20
Time-Varying Cardiovascular Outcomes of Sodium-Glucose Cotransporter Inhibitors in Patients With Type 2 Diabetes: A Post Hoc Analysis of Pivotal Trials Using Restricted Mean Survival Time	20
Evaluating the Implementation of Patient-Reported Outcomes in Heart Failure Clinic: A Qualitative Assessment	20
Long-Term Prognosis of Patients With Coexisting Obesity and Malnutrition After Acute Myocardial Infarction: A Cohort Study	19
Reserve and Resilience: A Framework to Inform Cardiovascular Disease Outcomes Research Among Older Adults	19
Improvements and Maintenance of Clinical and Functional Measures Among Rural Women: Strong Hearts, Healthy Communities-2.0 Cluster Randomized Trial	19
Cardiovascular Epidemiology: From Findings to Impact	19
Comparison of Associations of Food Security Instruments and Mediators With Premature All-Cause and Cardiovascular Disease Death in US Adults	19
Home Health Care Use and Outcomes After Coronary Artery Bypass Grafting Among Medicare Beneficiaries	18
Opportunistic Screening for Subclinical Atrial Fibrillation: It Is Cost-Effective, but Is It Effective?	18
Patient Characteristics Associated With Using Transcatheter Left Atrial Appendage Occlusion Versus Oral Anticoagulants for Atrial Fibrillation	18
To Test or Not to Test? The Utility of Noninvasive Cardiac Testing for Chest Pain Without Myocardial Infarction	18
Hospital Variability in the Use of Vasoactive Agents in Patients Hospitalized for Acute Decompensated Heart Failure for Clinical Phenotypes	17
Planning Ahead: Can Diagnosing Congenital Heart Disease Earlier Improve Outcomes?	17
Off-Label Dosing of Direct Oral Anticoagulants Among Inpatients With Atrial Fibrillation in the United States	16
Communicating Personalized Benefits of Conservative versus Invasive Treatment of Chronic Coronary Disease: Reflections From the Risk Communication Literature	16
Association Between Prenatal Diagnosis and Age at Surgery for Noncritical and Critical Congenital Heart Defects	16
How Should We Talk With Families After a Sudden Cardiac Death?	16
National Institutes of Health Stroke Scale Reporting in Medicare Claims Data: Reporting in the First 3 Years	16
Temporal Trends and Outcomes of Abdominal Aortic Aneurysm Care in the United States	16
Incidence and Survival of Out-of-Hospital Cardiac Arrest in Public Housing Areas in 3 European Capitals	16
Prescribing Mobile Health Applications	15
Association Between Prescription Drug Discount Cards and Out-of-Pocket Costs for HFrEF Regimens	15
Impact of In-Hospital Quality of Care Improvement Initiative on Secondary Prevention of Acute Coronary Syndrome in Six Months After Patient Discharge: A Large Stepped Wedge- and Cluster-Randomized Con	14
Past, Present, and Future of Shared Decision-Making	14
Practice Patterns and Outcomes Associated With Anticoagulation Use Following Sepsis Hospitalizations With New-Onset Atrial Fibrillation	14
Association Between Socioeconomic Disadvantage and Risks of Early and Recurrent Admissions Among Patients With Newly Diagnosed Heart Failure	14
Palliative Care Across the Life Span for Children With Heart Disease: A Scientific Statement From the American Heart Association	14

Cost-Effectiveness of Empagliflozin in Patients With Heart Failure and Preserved Ejection Fraction	14
Association Between Cardiac Rehabilitation and 1-Year Mortality by Frailty Level in Medicare Beneficiaries	13
Identifying and Addressing Gaps in the Care of Patients With Severe Valve Disease	13
What Is the Value of Routine Cardiovascular Care? Potential Lessons From the COVID-19 Pandemic	13
Impact of Embedding a Venous Thromboembolism Risk Assessment Model in the Electronic Health Record Versus Usual Care: A Cluster-Randomized Trial	13
American Heart Association National Integrated ASCVD Initiative: An Implementation Initiative to Improve Lipid Management Among Patients With ASCVD	13
Rethinking, Reimagining, and Reigniting Community-Engaged Research to Promote Cardiovascular Health Equity	13
Summertime for Cardiovascular AI	13
Performance of the American Heart Association PREVENT Cardiovascular Risk Equations in Older Adults	13
Association Between Market-Level Characteristics and Cardiologists Acquired by Private Equity in the United States	13
Patient Preferences for Features Associated With Leadless Versus Conventional Transvenous Cardiac Pacemakers	13
“ It’s Overwhelming With the Grief” A Qualitative Study of Families’ Experiences When a Young Relative Dies of Sudden Cardiac Death	12
Impact of Multidomain Frailty on the Mode of Death in Older Patients With Heart Failure: A Cohort Study	12
Understanding Cardiovascular Mortality: A Deep Dive Into the Differences Between GBD and CDC WONDER	12
Incidence of Timely Outpatient Follow-Up Care After Emergency Department Encounters for Acute Heart Failure	12
Cost-Effectiveness of AF Screening With 2-Week Patch Monitors: The mSToPS Study	12
Making Your Blood Boil: Challenges and Opportunities for Using Emergency Department Data to Understand the Impact of Structural Inequities on Health	12
High Time for High-Dose Flu Vaccines in Cardiovascular Patients?	12
Perioperative Considerations for Pediatric Patients With Congenital Heart Disease Presenting for Noncardiac Procedures: A Scientific Statement From the American Heart Association	12
Randomized Comparison of Online Motivational Themes in Clinical Trial Recruitment	11
Toward a Roadmap for Best Practices in Pediatric Preventive Cardiology: A Science Advisory From the American Heart Association	11
Why Are We Weighting? Understanding the Estimates From Propensity Score Weighting and Matching Methods	11
Therapeutic Inertia in Lipid-Lowering Treatment Intensification: Digital Tools and Performance Management to the Rescue?	11
Palliative Pharmacotherapy for Cardiovascular Disease: A Scientific Statement From the American Heart Association	11
Association Between Care Fragmentation and Total Spending After Durable Left Ventricular Device Implant: A Mediation Analysis of Health Care–Associated Infections Within a National Medicare-Society of	11
Contributions of Structural Racism to the Food Environment: A Photovoice Study of Black Residents With Hypertension in Baltimore, MD	11
Core Outcome Set for Studies on Cardiac Disease in Pregnancy (COSCarP): An International Delphi Consensus Study	11
Trends in Income Inequities in Cardiovascular Health Among US Adults, 1988–2018	10
Cost-Effectiveness of Quadruple Therapy in Management of Heart Failure With Reduced Ejection Fraction in the United States	10
In Pursuit of Health: Implementation Science and Community-Engaged Research in Cardiovascular Medicine	10
Exorbitant Drug Costs Lead to Inhumane Consequences	10
Updating the Accuracy of Administrative Claims for Identifying Left Ventricular Ejection Fraction Among Patients With Heart Failure	10
Cost-Effectiveness of Hypertension Treatment According to 2017 American College of Cardiology and American Heart Association Guidelines	10
Implementation of an Electronic Health Records–Based Safe Contrast Limit for Preventing Contrast-Associated Acute Kidney Injury After Percutaneous Coronary Intervention	10
Considering Social Context to Understand Childhood Adversities and Cardiovascular Health	10
Ten Steps Toward Improving In-Hospital Cardiac Arrest Quality of Care and Outcomes	10
Cardiovascular Risk Factor Management in Medicare Advantage and Traditional Medicare	10
Do Current Clinical Guidelines Set Percutaneous Coronary Intervention Up to Fail? Insights From the ORBITA-2 Trial	10
Codesign and Integration of a Promotora-Led Behavioral Health Intervention to Support Cardiovascular Risk Reduction in Latino Communities	10
Food Insecurity and Poor Health: Unraveling the Mechanisms, Informing Better Solutions	10
Psychological Outcomes and Interventions for Individuals With Congenital Heart Disease: A Scientific Statement From the American Heart Association	10
Defining a Minimal Benchmark for Cardiovascular Risk Prediction Calculators in New England Electronic Health Record–Derived Cohort	10
Trajectories of Frailty and Clinical Outcomes in Older Adults With Atrial Fibrillation: Insights From the Shizuoka Kokuho Database	10